Ditchcarbon
  • Contact
  1. Organizations
  2. Mankind Pharma
Public Profile
Pharmaceutical Preparation Manufacturing
IN
updated 2 days ago

Mankind Pharma

Company website

Mankind Pharma, a prominent player in the Indian pharmaceutical industry, is headquartered in New Delhi, India. Founded in 1991, the company has established itself as a leader in the development, manufacturing, and marketing of a diverse range of pharmaceutical products, including prescription medications, over-the-counter drugs, and consumer healthcare items. With a strong focus on quality and innovation, Mankind Pharma has achieved significant milestones, including rapid expansion across major operational regions in India and beyond. The company is renowned for its unique formulations and commitment to affordable healthcare, positioning itself as a trusted name among healthcare professionals and consumers alike. Notable achievements include a robust market presence and recognition for its contributions to the pharmaceutical sector, making Mankind Pharma a key player in enhancing health outcomes across the region.

DitchCarbon Score

How does Mankind Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

27

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Mankind Pharma's score of 27 is lower than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.

47%

Let us know if this data was useful to you

Mankind Pharma's reported carbon emissions

In 2024, Mankind Pharma reported total carbon emissions of approximately 5,831,000 kg CO2e from Scope 1 sources in India. This figure reflects a significant reduction from the previous year's emissions of about 14,519,000 kg CO2e, indicating a proactive approach to managing their carbon footprint. Globally, Mankind Pharma's emissions for 2024 included 5,831,000 kg CO2e from Scope 1 and 17,335,000 kg CO2e from Scope 2, totalling approximately 23,166,000 kg CO2e. The company has not disclosed any Scope 3 emissions data for this period. Despite the notable reductions, Mankind Pharma has not set specific science-based targets (SBTi) or documented reduction initiatives. The absence of formal climate pledges suggests that while the company is actively reducing emissions, it may not yet be aligned with industry-standard climate commitments. Overall, Mankind Pharma's emissions data demonstrates a commitment to reducing its carbon footprint, particularly in Scope 1 emissions, while further transparency and formal targets could enhance its climate strategy.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

202220232024
Scope 1
15,753,000
00,000,000
0,000,000
Scope 2
28,074,000
-
00,000,000
Scope 3
168,000
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Mankind Pharma's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Mankind Pharma is in IN, which has a very high grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Mankind Pharma is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Novartis

CH
•
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Piramal Pharma Limited

IN
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Bristol-Myers Squibb

US
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Abbott India Limited

IN
•
Pharmaceutical Preparation Manufacturing
Updated about 2 months ago

Sanofi

FR
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Aurobindo Pharma

IN
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251007.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy